New computer method aims to perfect blood thinner doses for transplant kids
NCT ID NCT05672550
Summary
This study tested a new computer-guided method to find the right dose of a blood thinner (enoxaparin) for children who just received a kidney transplant. The goal was to prevent dangerous blood clots in the new kidney without increasing the risk of serious bleeding. Researchers compared this new dosing method to the standard way doctors currently adjust the dose based on their experience.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Félix Guyon
La Réunion, France
-
Hôpital Mère Enfant
Lyon, France
-
Hôpital Necker - Enfants malades
Paris, Île-de-France Region, 75015, France
-
Hôpital Necker Enfants Malades
Paris, 75015, France
-
Hôpital Pellegrin
Bordeaux, 33000, France
-
Hôpital Robert Debré
Paris, 75019, France
-
Hôpital de Hautepierre
Strasbourg, France
-
Hôpital de la Villeneuve
Montpellier, France
-
Hôpital des Enfants
Toulouse, France
-
Hôtel Dieu
Nantes, France
Conditions
Explore the condition pages connected to this study.